Skip to main content
. 2001 Feb;51(2):174–176. doi: 10.1111/j.1365-2125.2001.01323.x

Table 1.

Use of ASA and other salicylates among 373 cases of SCAR and 1720 controls according to type of preparation.

Drug Type of preparation Cases Controls Crude relative risk estimate Multivariate relative risk estimate (95% confidence interval)
Any salicylates 47 133 1.7 1.3 (0.8,2.2)
ASA Single ingredient 31 92 1.6 1.5 (0.9,2.7)
Combination 6 12 2.4 1.6 (0.4,6.3)
Other salicylates Single ingredient 8 26 1.5 0.7 (0.2,2.7)
Combination 2 3